Update on Prolastin

According to Lorrie Kline Kaplan, director of the National Home Infusion Association (NHIA), Bayer Corporation has not responded to NHIA’s questions and concerns about the company’s new marketing arm Bayer Direct, as raised in letter NHIA sent to Bayer last November.

"We have been receiving calls from patients who called to register for their Prolastin with Bayer Direct in early November — as soon as they heard about the new program — and they still have not received a single shipment of Prolastin. They have been calling daily and cannot even get a return call from Bayer. Bayer can take a step in the right direction right now by establishing a task force of patients, providers, and physicians to set up a truly fair and equitable ongoing health care system for Prolastin patients."

Bayer representatives were unavailable for comment.